CHICAGO — Lipoprotein(a) has been shown to be an independent, causal and genetic risk factor for CVD, with higher prevalence in patients of African, South Asian, Asian and Oceanic ancestry, according to a presentation at the Cardiometabolic Health Congress. During his presentation, Patrick M. Moriarty, MD, FACC, FACP, professor of medicine and director of clinical pharmacology and the
Article by Healio: